Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c8cbbf2290b3f3a9988da29598baa2c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-54 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 |
filingDate |
2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8afdb76462edf38846e198ca974acfa3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ced8d4f6a02c36115fc6532fb2e6afcd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1ea7421f0e1df2d4a899aafd5047dc4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab88944f7b054a9830721d73ec6c87cf |
publicationDate |
2022-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2019392904-B2 |
titleOfInvention |
Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors |
abstract |
Compounds that inhibit p38α MAPK protein, and methods of using the same, are provided for treating or preventing diseases such as cancer or inflammatory diseases. |
priorityDate |
2018-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |